Ori Biotech
Anthony Davies is an experienced advisor in the biotech industry, having held various positions in companies such as BioLife Solutions, Inc., Capricor, Inc., and Geron Corporation. Anthony currently works at Ori Biotech, where they provide advice and support for the company's operations.
Davies has a long history of working in product development and manufacturing. Anthony began their career at Syrrx, where they were responsible for developing new processes for the company. Anthony then moved to ZymeQuest, where they oversaw manufacturing operations. After a brief stint at Park BioVentures LLC, they returned to product development as the Director of Process Development at Serologicals.
In 2006, Davies joined Geron Corporation as Vice President of Product Development. Anthony played a critical role in expanding Geron's cell-based therapeutic portfolio and negotiating corporate partnerships. Anthony left Geron in 2012 to join Capricor as Chief Technology Officer. At Capricor, they were responsible for manufacturing, quality systems, and product development. Anthony left Capricor in 2014 to join Dark Horse Consulting Group Inc.
Davies has been working in the biotech industry for over 20 years. Their experience and knowledge have made him an invaluable asset to Ori Biotech.
Anthony Davies has a PhD in Biochemical Engineering from the University of Birmingham and an MA in Natural Sciences (Biochemistry) from the University of Cambridge. Anthony also attended Brighton College.
This person is not in the org chart
This person is not in any offices
Ori Biotech
Ori Biotech is a London- and New Jersey-based innovator in CGT manufacturing that has developed a proprietary, bespoke and flexible manufacturing platform, which enables patient access to a new generation of personalized, life-saving treatments.